Renal dysfunction among rheumatoid arthritis patients: A retrospective cohort study

Annals of Medicine and Surgery - Tập 60 - Trang 280-284 - 2020
Ashraf O. Oweis1, Khaldoon M. Alawneh2, Sameeha A. Alshelleh3, Fatima Alnaimat4, Diala Alawneh5, Deeb Jamil Zahran6
1Division of Nephrology, Department of Medicine, Jordan University of Science and Technology, Irbid, Jordan
2Division of Rheumatology, Department of Medicine, Jordan University of Science and Technology, Irbid, Jordan
3Division of Nephrology, Department of Medicine, The University of Jordan, Amman, Jordan
4Division of Rheumatology, Department of Medicine, The University of Jordan, Amman, Jordan
5Department of Medicine, University of Missouri, Kansas City, MO, USA
6Department of Internal Medicine, Jordan University of Science and Technology, Irbid, Jordan

Tài liệu tham khảo

Alawneh, 2014, Rheumatoid arthritis in Jordan: a cross sectional study of disease severity and associated comorbidities, Therapeut. Clin. Risk Manag., 10, 363, 10.2147/TCRM.S62954 Widemann, 2006, Understanding and managing methotrexate nephrotoxicity, Oncol., 11, 694, 10.1634/theoncologist.11-6-694 Durando, 2017, Sulfasalazine-induced crystalluria causing severe acute kidney injury, Am. J. Kidney Dis., 70, 869, 10.1053/j.ajkd.2017.05.013 Braun, 2004, Rheumatoid arthritis and the kidney: uneasy companions, Nephron Clin. Pract., 96, c105, 10.1159/000077371 Liu, 2017, Focal segmental glomerulosclerosis lagged behind the onset of rheumatoid arthritis by 7 years: a case report and literature review, Medicine (Baltim.), 96, e5789, 10.1097/MD.0000000000005789 Muthukumar, 2017, Evaluation of renal lesions and clinicopathologic correlation in rheumatoid arthritis, Saudi J. Kidney Dis. Transpl., 28, 44, 10.4103/1319-2442.198118 Pathan, 2004, Rheumatoid arthritis and the kidney, J. Assoc. Phys. India, 52, 488 Agha, 2019, The STROCSS 2019 guideline: strengthening the reporting of cohort studies in surgery, Int. J. Surg., 72, 156, 10.1016/j.ijsu.2019.11.002 Arnett, 1988, The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis, Arthritis Rheum., 31, 315, 10.1002/art.1780310302 Kasturi, 2014, Comparison of the 1987 American College of Rheumatology and the 2010 American College of Rheumatology/European League against rheumatism criteria for classification of rheumatoid arthritis in the nurses' health study cohorts, Rheumatol. Int., 34, 407, 10.1007/s00296-013-2865-2 Berglin, 2013, Comparison of the 1987 ACR and 2010 ACR/EULAR classification criteria for rheumatoid arthritis in clinical practice: a prospective cohort study, Scand. J. Rheumatol., 42, 362, 10.3109/03009742.2013.776103 Aletaha, 2005, The simplified disease activity index (SDAI) and the clinical disease activity index (CDAI): a review of their usefulness and validity in rheumatoid arthritis, Clin. Exp. Rheumatol., 23, S100 White, 2019, Comparison of the new and traditional CKD-EPI GFR estimation equations with urinary inulin clearance: a study of equation performance, Clin. Chim. Acta, 488, 189, 10.1016/j.cca.2018.11.019 Mori, 2017, Prevalence of and factors associated with renal dysfunction in rheumatoid arthritis patients: a cross-sectional study in community hospitals, Clin. Rheumatol., 36, 2673, 10.1007/s10067-017-3804-5 Gijon-Conde, 2019, Impact of the European and American guidelines on hypertension prevalence, treatment, and cardiometabolic goals, J. Hypertens., 37, 1393, 10.1097/HJH.0000000000002065 Williams, 2018, ESC/ESH guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH), Eur. Heart J., 39, 3021, 10.1093/eurheartj/ehy339 Scott, 2010, Rheumatoid arthritis, Lancet, 376, 1094, 10.1016/S0140-6736(10)60826-4 Mittal, 2014, Rheumatological diseases and kidneys: a nephrologist's perspective, Int. J. Rheum. Dis., 17, 834, 10.1111/1756-185X.12424 Boers, 1987, Renal findings in rheumatoid arthritis: clinical aspects of 132 necropsies, Ann. Rheum. Dis., 46, 658, 10.1136/ard.46.9.658 Koivuniemi, 2016, Renal diseases in patients with rheumatoid arthritis, Scand. J. Rheumatol., 45, 432, 10.3109/03009742.2016.1143966 Saisho, 2016, Prevalence of chronic kidney disease and administration of RA-related drugs in patients with RA: the NinJa 2012 study in Japan, Mod. Rheumatol., 26, 331, 10.3109/14397595.2015.1088620 Couderc, 2016, Prevalence of renal impairment in patients with rheumatoid arthritis: results from a cross-sectional multicenter study, Arthritis Care Res., 68, 638, 10.1002/acr.22713 Chiu, 2015, Increased risk of chronic kidney disease in rheumatoid arthritis associated with cardiovascular complications - a national population-based cohort study, PloS One, 10, 10.1371/journal.pone.0136508 Tishko, 2011, Early diagnostics of kidney damage in longstanding rheumatoid arthritis and amyloidosis, Amyloid, 18, 217, 10.3109/13506129.2011.574354081 Sato, 2010, Cystatin C is a sensitive marker for detecting a reduced glomerular filtration rate when assessing chronic kidney disease in patients with rheumatoid arthritis and secondary amyloidosis, Scand. J. Rheumatol., 39, 33, 10.3109/03009740903042402 Hayashi, 2010, Elevated level of serum cystatin-C concentration is a useful predictor for myelosuppression induced by methotrexate for treatment of rheumatoid arthritis, Mod. Rheumatol., 20, 548, 10.3109/s10165-010-0315-5 Kapoor, 2018, Renal manifestations of rheumatoid arthritis, Rheum. Dis. Clin. N. Am., 44, 571, 10.1016/j.rdc.2018.06.008 Sumida, 2018, Treatment of rheumatoid arthritis with biologic agents lowers the risk of incident chronic kidney disease, Kidney Int., 93, 1207, 10.1016/j.kint.2017.11.025 Douville, 2009, Impact of age on glomerular filtration estimates, Nephrol. Dial. Transplant., 24, 97, 10.1093/ndt/gfn473 Stuveling, 2003, C-reactive protein is associated with renal function abnormalities in a non-diabetic population, Kidney Int., 63, 654, 10.1046/j.1523-1755.2003.00762.x Lipsky, 2000, Infliximab and methotrexate in the treatment of rheumatoid arthritis. anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study group, N. Engl. J. Med., 343, 1594, 10.1056/NEJM200011303432202 Nishimoto, 2007, Study of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor (SAMURAI): evidence of clinical and radiographic benefit from an x ray reader-blinded randomised controlled trial of tocilizumab, Ann. Rheum. Dis., 66, 1162, 10.1136/ard.2006.068064 Shinde, 2014, Methotrexate: a gold standard for treatment of rheumatoid arthritis, J. Pain Palliat. Care Pharmacother., 28, 351, 10.3109/15360288.2014.959238 Zhao, 2018, Etanercept for the treatment of rheumatoid arthritis, Immunotherapy, 10, 433, 10.2217/imt-2017-0155 Nakano, 1996, Determination of IgA- and IgM-rheumatoid factors in patients with rheumatoid arthritis with and without nephropathy, Ann. Rheum. Dis., 55, 520, 10.1136/ard.55.8.520